Growth Metrics

Bristol Myers Squibb (BMYMP) Inventory Average (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Inventory Average for 16 consecutive years, with $2.7 billion as the latest value for Q4 2025.

  • Quarterly Inventory Average fell 7.49% to $2.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 billion through Dec 2025, down 7.49% year-over-year, with the annual reading at $2.6 billion for FY2025, 0.54% up from the prior year.
  • Inventory Average for Q4 2025 was $2.7 billion at Bristol Myers Squibb, down from $2.7 billion in the prior quarter.
  • The five-year high for Inventory Average was $3.2 billion in Q3 2024, with the low at $2.0 billion in Q1 2021.
  • Average Inventory Average over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2023.
  • The sharpest move saw Inventory Average crashed 43.51% in 2021, then surged 33.52% in 2024.
  • Over 5 years, Inventory Average stood at $2.1 billion in 2021, then grew by 3.64% to $2.2 billion in 2022, then increased by 15.52% to $2.5 billion in 2023, then grew by 15.52% to $2.9 billion in 2024, then decreased by 7.49% to $2.7 billion in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $2.7 billion, $2.7 billion, and $2.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.